1 |
Feng J, Liu S, Ma S, et al. Protective effects of resveratrol on postmenopausal osteoporosis:regulation of SIRT1-NF-kappaB signaling pathway [J]. Acta Biochim Biophys Sin (Shanghai), 2014, 46(12): 1024-1033.
|
2 |
Somjen D, Katzburg S, Sharon O, et al. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line [J]. J Cell Biochem, 2011, 112(2): 625-632.
|
3 |
Li J, Chen X, Lu L, et al. The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis [J]. Cytokine Growth Factor Rev, 2020: 88-98.
|
4 |
《中国老年骨质疏松症诊疗指南》(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南(2018) [J].中国骨质疏松杂志, 2018, 24(12): 1541-1567.
|
5 |
汤淑女,尹香君,余卫,等.中国40岁及以上绝经后女性骨质疏松症患病率及其影响因素研究[J].中华流行病学杂志, 2022, 43(4): 509-516.
|
6 |
张伟,徐又佳,崔胜宇,等.联合检测血清铁蛋白和胱抑素C对绝经后骨质疏松症的意义[J].中国骨质疏松杂志, 2020, 26(9): 1274-1278.
|
7 |
Yu, Jiang, Bin, et al. Hepcidin protects against Iron overload-induced inhibition of bone formation in zebrafish [J]. Fish Physiol Biochem, 2019, 45(1): 365-374.
|
8 |
Kim Y. μSex, pregnancy, and age-specific differences of blood manganese levels in relation to iron status; what does it mean [J]? Toxicol Rep. 2017, 5: 28-30.
|
9 |
Zhao GY, Zhao LP, He YF, et al. A comparison of the biological activities of human osteoblast hFOB1.19 between Iron excess and Iron deficiency [J]. Biol Trace Elem Res, 2012, 150(1/3): 487-495.
|
10 |
Jeney Viktória. Clinical impact and cellular mechanisms of iron overload-associated bone loss [J]. Front Pharmacol, 2017, 8: 77.
|
11 |
Jian, J, Pelle, et al. Iron and menopause:does increased Iron affect the health of postmenopausal women [J]. Antioxid Redox Signal, 2009, 11(12): 2939-2943.
|
12 |
Li GF, Pan YZ, Sirois P, et al. Iron homeostasis in osteoporosis and its clinical implications [J]. Osteoporos Int, 2012, 23(10): 2403-2408.
|
13 |
Cai H, Zhang H, He W, et al. Iron accumulation and its impact on osteoporotic fractures in postmenopausal women[J]. J Zhejiang Univ Sci B. 2023, 24(4): 301-311.
|
14 |
中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017) [J].中国骨质疏松杂志, 2019, 25(3): 281-309.
|
15 |
Chen B, Li GF, Shen Y, et al. Reducing Iron accumulation:A potenial approach for the prevention and treatment of postmenopausal osteoporsis [J]. Exp Ther Med, 2015, 10(1): 7-11.
|
16 |
Zhang H, Wang AF, Shen GS, et al. Hepcidin-induced reduction in Iron content and PGC-1β expression negatively regulates osteoclast differentiation to play a protective role in postmenopausal osteoporosis [J]. Aging (Albany NY), 2021, 13(8): 11296-11314.
|
17 |
Xu GP, Li X, Zhu ZY, et al. Iron overload induces apoptosis and cytoprotective autophagy regulated by ROS Generation in Mc3t3-E1 cells [J]. Biol Trace Elem Res, 2021, 199(10): 3781-3792.
|
18 |
Italia K, Colah R, Ghosh K. Experimental animal model to study Iron overload and Iron chelation and review of other such models [J]. Blood Cells Mol Dis, 2015, 55(3): 194-199.
|
19 |
Tsay J, Yang Z, Ross FP, et al. Bone loss caused by Iron overload in a murine model: importance of oxidative stress [J]. Blood, 2010, 116(14): 2582-2589.
|
20 |
Simão M, Camacho A, Ostertag A, et al. Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis [J]. PLoS One, 2018, 13(11): e0207441.
|
21 |
Huang X, Xu YJ, Partridge NC. Dancing with sex hormones, could Iron contribute to the gender difference in osteoporosis? [J]. Bone, 2013, 55(2): 458-460.
|
22 |
Wang AF, Xu YJ. 2022.Influence of Iron accumulation on postmenopausal osteoporosis [J]. Chin J Osteoporos Bone Miner Res, 15(3): 225-231.
|
23 |
姚哲,王啸,李光飞,等.铁蓄积与绝经后髋部骨质疏松性骨折的相关性分析[J].中华创伤杂志, 2016, 32(6): 510-515.
|
24 |
Lu M, Liu Y, Shao M, et al. Associations of Iron Intake, Serum Iron and Serum Ferritin with Bone Mineral Density in Women: The National Health and Nutrition Examination Survey, 2005-2010 [J]. Calcif Tissue Int. 2020, 106(3): 232-238.
|
25 |
王爱飞,徐又佳.铁蓄积对绝经后骨质疏松症的影响[J].中华骨质疏松和骨矿盐疾病杂志, 2022, 15(3): 225-231.
|
26 |
林琳,林安平.铁过载对绝经后骨质疏松患者骨密度和骨代谢的影响[J].中国骨质疏松杂志, 2019, 25(12): 1747-1750.
|
27 |
Savvidis C, Tournis S, Dede AD. Obesity and bone metabolism [J]. Hormones (Athens), 2018, 17(2): 205-217.
|
28 |
Rinonapoli G, Pace V, Ruggiero C, et al. Obesity and bone: a complex relationship [J]. Int J Mol Sci, 2021, 22(24): 13662.
|
29 |
Litwic AE, Westbury LD, Ward K, et al. Adiposity and bone microarchitecture in the GLOW study [J]. Osteoporos Int, 2021, 32(4): 689-698.
|
30 |
Liu HF, Meng DF, Yu P, et al. Obesity and risk of fracture in postmenopausal women: a meta-analysis of cohort studies [J]. Ann Med, 2023, 55(1): 2203515.
|
31 |
López-Gómez JJ, Pérez-Castrillón JL, García de Santos I, et al. Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women [J]. Nutrients, 2022, 14(8): 1617.
|
32 |
Covic A, Vervloet M, Massy ZA, et al. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population [J]. Lancet Diabetes Endocrinol, 2018, 6(4): 319-331.
|
33 |
王龙梅,刘康佳,刘子欣,等.脂代谢及相关疾病与骨质疏松症关系研究进展[J].中国骨质疏松杂志, 2021, 27(5): 767-770, 775.
|
34 |
Kosmin M, Padhani AR, Gogbashian A, et al. Comparison of Whole-Body MRI, CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone [J]. Radiology, 2020, 297(3): 622-629.
|